RELPAX

This brand name is authorized in Austria, Australia, Canada, Germany, Spain, France, Hong Kong, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RELPAX contains one active pharmaceutical ingredient (API):

1 Eletriptan
UNII M41W832TA3 - ELETRIPTAN HYDROBROMIDE

Eletriptan is a selective agonist at the vascular 5-HT1B and neuronal 5-HT1D receptors. Eletriptan also exhibits high affinity for the 5-HT1F receptor which may contribute to its anti-migraine mechanism of action.

Read about Eletriptan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RELPAX Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02CC06 Eletriptan N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 5290K, 5291L
Country: CA Health Products and Food Branch Identifier(s): 02256290, 02256304
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01658658, 01658687, 03932804, 03932810, 03932827, 03932833, 03934306, 03934393, 06974714, 07005710, 09423179, 11689967, 12526902, 13332376, 13332382, 13781826, 14256789, 17448242
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 64124, 64125
Country: FR Base de données publique des médicaments Identifier(s): 63476564, 64350636
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 146202, 34000, 34036, 374138, 381652
Country: HK Department of Health Drug Office Identifier(s): 66729
Country: IE Health Products Regulatory Authority Identifier(s): 54287, 72122
Country: IT Agenzia del Farmaco Identifier(s): 035307103, 035307281, 035307305
Country: JP 医薬品医療機器総合機構 Identifier(s): 2160005F1021
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 050M2000
Country: NL Z-Index G-Standaard, PRK Identifier(s): 60232
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8591, 8592, 8593
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100109142
Country: SG Health Sciences Authority Identifier(s): 11767P, 11768P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 14573021
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699532090881, 8699532095176, 8699532096418
Country: US FDA, National Drug Code Identifier(s): 0049-2330, 0049-2340, 63539-234
Country: ZA Health Products Regulatory Authority Identifier(s): 34/7.3/0077, 34/7.3/0078, 34/7.3/0079

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.